Medicine News and Research

RSS

FDA warns manufacturers of caffeinated alcoholic beverages

The U.S. Food and Drug Administration today warned four companies that the caffeine added to their malt alcoholic beverages is an "unsafe food additive" and said that further action, including seizure of their products, is possible under federal law.

18 Nov 2010

Titan Spine granted FDA clearance for Endoskeleton TO system

Titan Spine, a developer of novel interbody fusion implants, announced today that it has received FDA clearance to commercially release its Endoskeleton® TO system, which consists of a line of interbody devices placed through a Posterior Lumbar Interbody Fusion (PLIF) approach. The company plans to commercially release the product beginning in December, 2010.

18 Nov 2010

Rheonix receives U.S patent for microfluidic device

Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.

18 Nov 2010

VX-770 drug candidate improves lung function in people with cystic fibrosis

In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.

18 Nov 2010

Viruses lead to discovery of security system in host cells

Viruses have led scientists at Washington University School of Medicine in St. Louis to the discovery of a security system in host cells.

18 Nov 2010

Selenium secures NIH grant to apply patented antimicrobial technology for ear infections

Selenium, Ltd., a biopharmaceutical company focused on unique solutions to meet antimicrobial coating and therapeutic needs, has been awarded a research grant from the National Institute on Deafness and Other Communication Disorders, one of the National Institutes of Health. With the $155,387 NIH grant the company will apply its proprietary antimicrobial technology to researching the inhibition of biofilms on tympanostomy tubes.

18 Nov 2010

New pharmacogenetic test enables a personalized medicine approach

Luminex Corporation, today announced that it has commercially launched its first pharmacogenetic test, the xTAG CYP2D6 Kit, which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

From Luminex 17 Nov 2010

New investigational drug improves lung function in CF patients

An investigational drug targeting a defective protein that causes cystic fibrosis has been shown to improve lung function in a small study of CF patients, according to findings published Nov. 18, 2010, in the New England Journal of Medicine.

17 Nov 2010

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

A 28-year old man from Georgia, David Krech, is recovering from a rare, lifesaving heart/liver transplant on October 15 at the University of Maryland Medical Center. The 13-hour operation followed a five-month journey as he awaited a suitable heart and liver donor.

17 Nov 2010

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Rolling back suggestions from previous studies, a Johns Hopkins study of 950 healthy men and women has shown that taking daily doses of a cholesterol-lowering statin medication to protect coronary arteries and ward off heart attack or stroke may not be needed for everyone.

17 Nov 2010

Combination of two devices increases long-term survival in cardiac arrest patients

A combination of two devices could save the lives of several thousand cardiac arrest patients each year if implemented nationwide, suggests results of a clinical trial presented at today's American Heart Association Resuscitation Science Symposium.

17 Nov 2010

Cardiac surgery leads to stroke, seizure and neurological complications: Report

Strokes, seizures and other neurological complications related to heart surgery account for "considerable morbidity and mortality," Loyola University Health System neurologists report in the November issue of the journal Hospital Practice.

17 Nov 2010

NT-proBNP guided heart failure care associated with reduced cardiovascular events

Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death

From Roche Sequencing and Life Science 17 Nov 2010

Duke awarded $52.8M federal grant to oversee external quality assurance programs for HIV/AIDS labs

The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), has awarded Duke University Medical Center up to $52.8 million over the next seven years to support the development, implementation and oversight of external quality assurance programs that monitor laboratories involved in HIV/AIDS research and vaccine trials around the world.

17 Nov 2010

8 states get better grade on 2010 March of Dimes Premature Birth Report Card

Eight states earned a better grade on the 2010 March of Dimes Premature Birth Report Card and 32 others and the District of Columbia saw their preterm birth rates improve.

17 Nov 2010

Cardio3 BioSciences announces positive results from C-Cure Phase II clinical trial for heart failure

The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.

17 Nov 2010

Better strategies beyond the legal arena needed to prevent sexual abuse among children and teens

The increase in the legal age of sexual consent from 14 to 16 years in 2008 may not be protecting those at greatest risk, according to researchers who have analyzed British Columbia population-based data and recommend additional strategies to safeguard vulnerable children and teens.

17 Nov 2010

New technique to purify propolis

The healing properties of propolis a mixture of resin and wax made by honey bees to seal and sterilise their hives have been known for many years. But its use in medicine and food supplements has been limited because the sticky substance is not water soluble and has a strong, off-putting smell.

17 Nov 2010

Study finds gender differences linked to gaming and health risks associated with problematic gaming

A new study on gaming and health in adolescents, conducted by researchers at Yale School of Medicine, found some significant gender differences linked to gaming as well as important health risks associated with problematic gaming. Published today in the journal Pediatrics, the study is among the first and largest to examine possible health links to gaming and problematic gaming in a community sample of adolescents.

17 Nov 2010

Pilot registry to identify AEDs in the community

Monday, Food and Drug Administration officials announced that the University of Colorado School of Medicine will work with the FDA to develop a pilot registry in Denver to identify AEDs in the community. This registry will link AEDs to emergency medical dispatch. It also could increase the ability of bystanders to save a life and help ensure that AEDs are located where they might be needed. Seattle and San Diego are the only other cities that will launch this effort.

17 Nov 2010

Medicine News and Research

FDA warns manufacturers of caffeinated alcoholic beverages

Titan Spine granted FDA clearance for Endoskeleton TO system

Rheonix receives U.S patent for microfluidic device

VX-770 drug candidate improves lung function in people with cystic fibrosis

Viruses lead to discovery of security system in host cells

Selenium secures NIH grant to apply patented antimicrobial technology for ear infections

New pharmacogenetic test enables a personalized medicine approach

New investigational drug improves lung function in CF patients

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Combination of two devices increases long-term survival in cardiac arrest patients

Cardiac surgery leads to stroke, seizure and neurological complications: Report

NT-proBNP guided heart failure care associated with reduced cardiovascular events

Duke awarded $52.8M federal grant to oversee external quality assurance programs for HIV/AIDS labs

8 states get better grade on 2010 March of Dimes Premature Birth Report Card

Cardio3 BioSciences announces positive results from C-Cure Phase II clinical trial for heart failure

Better strategies beyond the legal arena needed to prevent sexual abuse among children and teens

New technique to purify propolis

Study finds gender differences linked to gaming and health risks associated with problematic gaming

Pilot registry to identify AEDs in the community

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News